Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.37 |
| ▸ | HMGCR | P04035 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 2/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | XDH | P47989 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PRKCI | P41743 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27689112 | 0.83 | GABRA1 (0.47) | KDM4EGAAGLAGABRA1GABRB2 | |
| SCHEMBL1743958 | 0.79 | PRKCI (0.44) | KDM4EGAADHFRGABRA1GABRB2 | |
| SCHEMBL11891611 | 0.78 | GABRA1 (0.46) | KDM4EGAADHFRGABRA1GABRB2 | |
| SCHEMBL9028351 | 0.78 | CYP19A1 (0.41) | KDM4EGAAGLADHFRGABRA1 | |
| SCHEMBL5589047 | 0.77 | HMGCR (0.42) | KDM4EHMGCRALOX5PRKCIMEN1 | |
| SCHEMBL17612610 | 0.77 | KDM4E (0.43) | KDM4EHMGCRCYP19A1ALOX5PRKCI | |
| SCHEMBL27644801 | 0.76 | DHFR (0.44) | KDM4EGAAGLADHFRGABRA1 | |
| SCHEMBL3045553 | 0.76 | GABRA1 (0.47) | KDM4EGAAGLAGABRA1GABRB2 | |
| SCHEMBL9028140 | 0.75 | KDM4E (0.38) | KDM4EGAAGLADHFRGABRA1 | |
| SCHEMBL11874173 | 0.75 | XDH (0.45) | KDM4EGAAGLAGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9302967-B2 | Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-05 | — | — | US | claimed |
| US-20140135393-A1 | SUBSTITUTED CATHECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-05-15 | — | — | US | claimed |
| WO-2012140574-A1 | SUBSTITUTED CATECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-10-18 | — | — | WO | claimed |
| EP-2385934-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | Council of Scientific & Industrial Research (IN) | 2011-11-16 | — | — | EP | claimed |
| US-8041964-B2 | Ultra low power wake-up circuit | COVIDIEN AG (CH) | 2011-10-18 | — | — | US | claimed |
| WO-2010079423-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-07-15 | — | — | WO | claimed |
| EP-2385934-B1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL SCIENT IND RES (IN) | 2016-05-18 | — | — | EP | disclosed |
| US-9302967-B2 | Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-05 | — | — | US | disclosed |
| US-9302967-B2 | Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-05 | — | — | US | disclosed |
| US-9302967-B2 | Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-04-05 | — | — | US | disclosed |
| US-9290473-B2 | Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO) | COUCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-03-22 | — | — | US | disclosed |
| US-9290473-B2 | Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO) | COUCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-03-22 | — | — | US | disclosed |
| US-20140135393-A1 | SUBSTITUTED CATHECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-05-15 | — | — | US | disclosed |
| WO-2012140574-A1 | SUBSTITUTED CATECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-10-18 | — | — | WO | disclosed |
| US-20120190738-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-07-26 | — | — | US | disclosed |
| US-20120190738-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2012-07-26 | — | — | US | disclosed |
| EP-2385934-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | Council of Scientific & Industrial Research (IN) | 2011-11-16 | — | — | EP | disclosed |
| US-8041964-B2 | Ultra low power wake-up circuit | COVIDIEN AG (CH) | 2011-10-18 | — | — | US | disclosed |
| WO-2010079423-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-07-15 | — | — | WO | disclosed |
| WO-2010079423-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135393-A1 | SUBSTITUTED CATHECHOLS AS INHIBITORS OF IL-4 AND IL-5 FOR THE TREATMENT BRONCHIAL ASTHMA | IL5, IL4, IL33 | KDM4E 1050/4885GAA 2924/4885GLA 1895/4885 |
| US-20120190738-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3) AND INDUCERS OF NITRIC OXIDE (NO) | NOS2, NOS3, NOS1 | KDM4E 2859/4885GAA 2017/4885GLA 2292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.